Aug 15, 2024
289:200
For every 200 shares held, investors received 289. The price per share adjusted from $3.22 to $2.23.
The split itself did not change the total investment value.
Ascelia Pharma AB (STO:ACE) operates in the Pharmaceuticals: major industry.
Ascelia Pharma AB company overviewAscelia Pharma AB's most recent stock split was on August 15, 2024. It was a 289-for-200 forward split, so shareholders received 289 shares for every 200 they held.
Ascelia Pharma AB has split its stock once. This history records one forward split, on August 15, 2024.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Ascelia Pharma AB's 289-for-200 split on August 15, 2024, every 200 shares became 289 shares.
Ascelia Pharma AB has not announced a new split in our records. Its most recent split was on August 15, 2024, 2 years ago. Companies announce splits in advance, and any new STO:ACE split will appear on this page.
Already premium?